Can quality of life assessments differentiate heterogeneous cancer patients?
about
Targeted drugs and Psycho-oncological intervention for breast cancer patientsFatigue as a Driver of Overall Quality of Life in Cancer Patients.Quality of life after cancer-How the extent of impairment is influenced by patient characteristics.Validation of the PROMIS physical function measures in a diverse US population-based cohort of cancer patients.
P2860
Can quality of life assessments differentiate heterogeneous cancer patients?
description
2014 nî lūn-bûn
@nan
2014 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Can quality of life assessments differentiate heterogeneous cancer patients?
@ast
Can quality of life assessments differentiate heterogeneous cancer patients?
@en
type
label
Can quality of life assessments differentiate heterogeneous cancer patients?
@ast
Can quality of life assessments differentiate heterogeneous cancer patients?
@en
prefLabel
Can quality of life assessments differentiate heterogeneous cancer patients?
@ast
Can quality of life assessments differentiate heterogeneous cancer patients?
@en
P2093
P2860
P1433
P1476
Can quality of life assessments differentiate heterogeneous cancer patients?
@en
P2093
Donald P Braun
James F Grutsch
Maurie Markman
Ryan M McCabe
Swetha B Nutakki
P2860
P304
P356
10.1371/JOURNAL.PONE.0099445
P407
P577
2014-06-11T00:00:00Z